This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
O-Desmethyltramadol
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-PERMANENT — risk:benefit fails for the canonical archetype.
Our depth — beyond the mirror
Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.
▸ Editor's verdict SKIP-PERMANENT HIGH
Buying O-DSMT bypasses the natural CYP2D6 metabolic gate that makes tramadol relatively safe in CYP2D6 normal/poor metabolizers (~7% of European-descent population have ultrarapid CYP2D6 and convert too much tramadol → opioid toxicity; conversely poor metabolizers convert too little → poor analgesia). Isolated M1 gives the ultrarapid-metabolizer dose to everyone. Respiratory depression + dependence risk equivalent to other moderate-strength opioids. SKIP-PERMANENT.
▸ Verdict change log
- 2026-06-05 — Initial verdict SKIP-PERMANENT. (stub)
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.